Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Enzyme replacement therapy: conception, chaos and culmination.

Roscoe O Brady1

  • 1Developmental and Metabolic Neurology Branch, National Institute of Neurological Disorders and Stroke, Building 10, Room 3D04, National Institutes of Health, 9000 Rockville Pike, Bethesda, MD 20892-1260, USA. bradyr@ninds.nih.gov

Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences
|June 14, 2003
PubMed
Summary

Enzyme replacement therapy (ERT) offers a promising treatment for metabolic storage disorders. Successful ERT for Gaucher and Fabry diseases demonstrates its potential for other genetic conditions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cannabis and tobacco co-use predicts psychosis in clinical high risk cohorts.

Nature. Mental health·2026
Same author

Tobacco Use is Related to Parietal-Hippocampal Connectivity in People at Clinical High Risk for Psychosis.

medRxiv : the preprint server for health sciences·2026
Same author

Cannabis and Tobacco Co-Use Is Associated With Impaired Neurocognitive Performance in Individuals at Clinical High Risk for Psychosis.

Biological psychiatry. Cognitive neuroscience and neuroimaging·2026
Same author

A Novel Therapeutic Mechanism for Nicotine Craving in Schizophrenia.

medRxiv : the preprint server for health sciences·2026
Same author

Network-targeted TMS modulates nicotine craving and default mode network connectivity in psychotic disorders.

Brain stimulation·2026
Same author

Accelerated DMN-Targeted cTBS Improves Processing Speed Deficits in Schizophrenia.

medRxiv : the preprint server for health sciences·2026

Area of Science:

  • Biochemistry
  • Genetics
  • Medical Science

Background:

  • Metabolic storage disorders arise from enzymatic defects.
  • Early research identified enzyme deficiencies in Gaucher and Niemann-Pick diseases.
  • Enzyme replacement was proposed as a targeted therapy for these conditions.

Purpose of the Study:

  • To review the development and success of enzyme replacement therapy (ERT) for metabolic storage disorders.
  • To highlight the challenges and achievements in implementing ERT.
  • To emphasize the potential of ERT for treating a broader range of metabolic diseases.

Main Methods:

  • Development of large-scale enzyme production for clinical use.
  • Strategies for targeting therapeutic enzymes to affected cells.

Related Experiment Videos

  • Clinical trials to evaluate the efficacy of ERT.

    • Main Results:

    • Successful enzyme replacement therapy (ERT) developed for Gaucher disease.
    • Effective ERT established for Fabry disease.
    • Demonstrated feasibility of enzyme production and cellular targeting for therapeutic enzymes.

    Conclusions:

    • Enzyme replacement therapy is a viable treatment for specific metabolic storage disorders.
    • The success in Gaucher and Fabry diseases provides a strong foundation for applying ERT to other genetic metabolic conditions.
    • Further research and development in enzyme production and delivery are crucial for expanding ERT applications.